QA: BALCHEM CORP in us_medicinal_products/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2018_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 183,964,000
1 LiabilitiesCurrent 108,396,000
2 remainder_Liabilities 54,395,000
3 AssetsCurrent 199,336,000
4 AssetsNoncurrent 5,073,000
5 PropertyPlantAndEquipmentNet 189,793,000
6 Goodwill 569,434,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 488,230,000
9 ResearchAndDevelopmentExpense 9,305,000
10 remainder_Expenses 5,961,000
11 remainder_Revenues 594,790,000
12 remainder_NetIncome -1,223,000
13 remainder_ComprehensiveNetIncome 5,207,000
  yvar yval
0 Liabilities 346,755,000
1 Assets 963,636,000
2 Expenses 503,496,000
3 Revenues 594,790,000
4 StockholdersEquity 616,881,000
5 NetIncome 90,071,000
6 ComprehensiveNetIncome 92,674,500
7 BaseVar 1,207,553,500
8 EconomicCapitalRatio 0.942

Edgar->Model Mapping

Feature Distribution

Change over Time